Proteomics signs PromarkerD agreement with US big pharma

Building on the company’s recent licensing deals for PromarkerD as a predictive test for diabetic kidney disease, Proteomics International is pleased to announce it has signed a research collaboration agreement with Janssen Research & Development LLC, for diabetic kidney disease treatment research.

Media release


  • This field is for validation purposes and should be left unchanged.